| 영문 | epidemic parotitis, mumps | 한글 | 볼거리, 유행귀밑샘염 |
|---|---|---|---|
| 설명 | 주로 소아에서 일어나고, 그 결과로 지속성 면역을 주는 전염성의 paramyxovirus 병. 흡기에 의해서 감염되는데, 가장 농후한 바이러스감염은 침샘내에 생기며, 특히 턱밑샘이나 혀밑샘보다도 귀밑샘이 더욱 심하다. 잠복기는 18~22일이다. 감염은 약 75%의 증례에서 증상을 나타낸다. 이들 중 귀밑샘염은 70%에서, 수막염은 10~15%(이들 중 반수에서 무증상성 수액세포 증가증이 동반된다)에서 일어난다. 부고환고환염이 사춘기 후의 남성에서 생기지만 그 후에 불임증을 속발하는 일은 드물다. 그 외의 증상은 보다 드물게 나타나는데 이자염, 관절염, 심근염, 난소염, 갑상샘염 및 젖샘염 등이 있다. 발열과 환부의 유통성 염증은 최초의 2일간에 가장 현저하고 다음 4~5일이 지나면 서서히 가라앉는다. 동시에 한 부위 이상을 침습하는 수도 있으며 가끔 속발적으로 침습되고 질환의 전 경과는 2~3주에 이른다. 부수되는 영속성의 신경학적 손상을 동반하는 수막뇌염은 드물다. |
||
| 영문 | iodine uptake | 한글 | 요오드 섭취 |
|---|---|---|---|
| 설명 | 소량의 131I를 경구 투여 후 2, 6, 12, 24시간 등 일정한 시간 경과 후 갑상샘에서의 섭취율을 측정하는 것으로 전반적 갑상샘 기능 상태를 측정하는 검사법이다. |
||
| 영문 | iodine | 한글 | 요오드, 옥소 |
|---|---|---|---|
| 설명 | 비금속 원소. 기호 I. 원자번호 53. 갑상샘 호르몬인 thyroxine과 triiodothyronine의 합성에 필요한 필수 영양소이다. 또한 요오드 용액은 국소적인 항균제로 사용되기도 한다. |
||
| 영문 | iodine | 한글 | 요오드 |
|---|---|---|---|
| 설명 | 1. 특이한 냄새와 쓴맛을 가진 할로겐 원소의 하나. 금속성의 광택과 특이적 냄새를 갖는 흑회색의 판상, 또는 과립상의 결정으로, 그 용액은 강한 살균력을 갖는 소독제이다. 세균, 진균에 광범위하게 살균작용을 나타내며, 석탄산지수는 약 200으로, 그 작용기전은 세균의 대사계산소의 저해에 의한다고 한다. 본제는 물에 잘 녹지 않으므로 용해보조제로서 요오드화칼륨을 가해 수용성 착화합물을 만든 후, 물이나 에탄올에 녹여 제제로 만든다. 소독, 방부, 국소자극제로 쓰인다. 요오드는 필수영양소이며, 갑상샘콜로이드중에 특히 풍부하게 존재한다. 2. 요오드제. 표준품은 99.8% 이상 100.5% 이하의 요오드를 함유하고 국소살균제로 쓰인다. 요오드화물의 형태로서 요오드는 보통 갑상샘기능 항진증의 치료에 사용된다. |
||
| MMR | 1) Measles, Mumps, Rubella; 홍역, 멈프스, 풍진 2) Mass Miniature Radiography... |
|---|---|
| MMR | mass miniature radiography; masseter muscle rigidity; maternal mortality rate; measles-mumps-rubella... |
| MUMPS | Massachusetts General Hospital Utility Multi-Programming System |
| 131I | radioactive Iodine(used in Thyroid uptake, Liver & Kidney Scans & Treatment of malignant & nonmalig... |
| PBI | 1) Penile Brachial Index 2) Protein-Bound Iodine; 단백 결합 요오드 |
| MMR | MEASLES: mumps-rubella |
|---|---|
| MMR | Measles, mumps and rubella |
| MMR | Measles-Mumps-Rubella vaccine |
| MuV | Mumps virus |
| (125)I | 125)iodine |
powder (분말, 산제
| vaccination, mumps | See Vaccination, MMR. Vaccination, pneumococcal pneumonia: this vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
|---|---|
| measles, mumps and rubella vaccine | A combination of live attenuated measles, mumps, and rubella viruses in an aqueous suspension; used for immunization against the respective diseases. (05 Mar 2000) |
| metastatic mumps | Mumps complicated by involvement of organs other than parotid glands, such as the testis, breast, or pancreas. (05 Mar 2000) |
| mumps | An infectious acute viral disease affecting the parotid glands. The gonads, meninges and pancreas can also be affected. The causative agent is a paramyxovirus. Humans are the only natural host for this disease. Common symptoms include weakness, fever, sore throat, malaise and puffiness to the cheeks (due to parotid gland swelling). Patients are contagious 1 day prior to the onset of swelling until the swelling is gone. Recovery is generally in 2 weeks. (27 Sep 1997) |
| mumps immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| mumps in pregnancy | It has been stated, we believe erroneously, that mumps is dangerous when contracted during pregnancy. For example, vetter (infect med 14:730-733, 1997), citing a single 1980 article, writes: mumps infection during the first trimester of pregnancy can increase the rate of spontaneous abortion. Congenital anomalies associated with mumps infection during pregnancy include endocardial fibroelastosis; imperforate anus; spina bifida; and auditory, optic, and urogenital deformities. However, shepard in his authorative catalog of teratogenic agents (j hopkins u press, 8th edition, 1995) does not consider that mumps merits inclusion as a proven or even possible teratogenic agent, that is as an agent capable of causing a spontaneous abortion (a miscarriage) or causing congenital malformations (the baby is born with birth defects). Furthermore, mumps does not even warrant mention in smith's recognizable patterns of human malformation (by kl jones, wb saunders co., 5th edition, 1997), a key standard text on dysmorphology (the study of malformations). Based also on our review of the facts available at this time (oct, 1997), we conclude that there is insufficient evidence to label mumps as a particular hazard in pregnancy. (12 Dec 1998) |
| mumps meningoencephalitis | A usually benign nervous system infection arising during the active phase of clinical mumps parotiditis. (05 Mar 2000) |
| mumps orchitis | <pathology> A mumps infection that has affected the testicles. Approximately 20-35% of postpubertal males with mumps will develop this complication. (27 Sep 1997) |
| mumps sensitivity test | A skin test for sensitivity to mumps, in which inactivated mumps virus is used as antigen. (05 Mar 2000) |
| mumps skin test antigen | A sterile suspension of killed mumps virus in isotonic sodium chloride solution, used to determine susceptibility to mumps or to confirm previous exposure. (05 Mar 2000) |
| mumps vaccine | A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunised with live mumps vaccine. Children are usually immunised with measles-mumps-rubella combinatiom vaccine. (12 Dec 1998) |
| mumps virus | The type species of rubulavirus that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection. (12 Dec 1998) |
| mumps virus vaccine | Vaccine containing live, attenuated mumps virus prepared in chick embryo cell cultures. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
| immunization, mumps | See Immunization, MMR. (12 Dec 1998) |
| butanol-extractable iodine | Iodine that can be separated from plasma proteins by butanol or other extractable solvents; used to measure thyroid function. (05 Mar 2000) |
| iodine mumps |
swelling of the salivary and lacrimal glands as a toxic reaction to iodine therapy.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|